Stallion India Fluorochemicals Schedules Q4 & FY 2025-26 Earnings Conference Call for May 18, 2026

1 min read     Updated on 12 May 2026, 07:32 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Stallion India Fluorochemicals Limited has scheduled its Q4 & FY 2025-26 Earnings Conference Call for Monday, May 18, 2026, at 04:00 PM IST. The call will be conducted via Zoom webinar (Meeting ID: 973 6123 8414, Passcode: 480895) and requires prior registration. Managing Director & CEO Mr. Shazad Rustomji will represent the management during the call. The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

powered bylight_fuzz_icon
40140129

*this image is generated using AI for illustrative purposes only.

Stallion India Fluorochemicals Limited has announced an earnings conference call to discuss its financial results for the Quarter and Financial Year ended March 31, 2026. The intimation was filed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was communicated to the National Stock Exchange of India Limited and BSE Limited on May 12, 2026.

Conference Call Details

The earnings call is scheduled for Monday, May 18, 2026, at 04:00 PM IST. Investors and analysts can participate via a Zoom webinar, which requires prior registration. The following table summarises the key details of the event:

Parameter: Details
Date: Monday, May 18, 2026
Time: 04:00 PM IST
Platform: Zoom Webinar
Meeting ID: 973 6123 8414
Passcode: 480895
Registration Link: https://zoom.us/webinar/register/WN_p0b8xNDSSTCJYEbeVflm6Q

Speaker From Management

The conference call will be addressed by the following member of the company's senior management:

  • Mr. Shazad Rustomji – Managing Director & CEO

For More Information

Investors and analysts seeking further details regarding the earnings call may reach out to the investor relations coordinator, ConfideLeap Partners, through the following channels:

Contact: Details
Phone: +(91) 85911 45959
Email: info@confideleap.com
Website: www.confideleap.com
Address: 103-8, Lodha Eternis, MIDC, Andheri East, Mumbai 400093, Maharashtra, India

The filing was signed by Govind Rao, Company Secretary & Compliance Officer (Membership No. A47094), on behalf of Stallion India Fluorochemicals Limited.

Historical Stock Returns for Stallion India Fluorochemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-3.31%-7.78%+7.57%-33.95%+119.18%+16.90%

How has Stallion India Fluorochemicals' revenue and margin trajectory evolved over FY2026, and what guidance is management likely to provide for FY2027?

Given the growing global demand for fluorochemicals in EV batteries and semiconductors, how is Stallion India positioning itself to capitalize on these emerging opportunities?

What impact could potential changes in China's fluorochemical export policies have on Stallion India's competitive positioning and pricing power in domestic and international markets?

Stallion India Fluorochemicals
View Company Insights
View All News
like15
dislike

Stallion India Fluorochemicals Schedules Board Meeting on May 13, 2026 to Approve FY26 Annual Audited Financial Statements

1 min read     Updated on 10 May 2026, 04:09 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Stallion India Fluorochemicals has intimated stock exchanges on May 10, 2026, of a Board of Directors meeting scheduled for May 13, 2026. The meeting is being held pursuant to Regulation 29 of SEBI (LODR) Regulations, 2015. The board will consider, approve, and take on record the Annual Audited Financial Statements for the financial year ended March 31, 2026, along with the auditors' reports. The intimation was signed by Company Secretary & Compliance Officer Govind Rao.

powered bylight_fuzz_icon
39955184

*this image is generated using AI for illustrative purposes only.

Stallion India Fluorochemicals has notified the stock exchanges of an upcoming Board of Directors meeting, scheduled for Wednesday, 13th May, 2026. The intimation was issued on 10th May, 2026, in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Agenda

The meeting has been convened with a specific and significant agenda item. The Board will deliberate upon and formally record the company's financial results for the concluded fiscal year.

Parameter: Details
Meeting Date: Wednesday, 13th May, 2026
Intimation Date: 10th May, 2026
Regulatory Basis: Regulation 29 of SEBI (LODR) Regulations, 2015
Agenda: Consider, approve & take on record the Annual Audited Financial Statements for the financial year ended 31st March, 2026, along with the Reports of the Auditors thereon

Regulatory Compliance

The intimation was submitted to both the National Stock Exchange of India Limited (NSE) and BSE Limited, in accordance with the company's obligations under the applicable listing regulations. The communication was signed by Govind Rao, Company Secretary & Compliance Officer of Stallion India Fluorochemicals.

The board meeting represents a key corporate event as it will culminate in the formal adoption of the company's audited annual financial results for the financial year ended 31st March, 2026.

Historical Stock Returns for Stallion India Fluorochemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-3.31%-7.78%+7.57%-33.95%+119.18%+16.90%

How might Stallion India Fluorochemicals' FY2026 annual results compare to the previous year's performance, given the evolving demand dynamics in the fluorochemicals sector?

Will the board meeting on May 13th also address any dividend announcements or capital allocation decisions alongside the financial results approval?

How could potential changes in India's fluorochemicals industry regulations or global supply chain shifts impact Stallion India's financial outlook for FY2027?

Stallion India Fluorochemicals
View Company Insights
View All News
like18
dislike

More News on Stallion India Fluorochemicals

1 Year Returns:+119.18%